臨床微生物学の世界市場予測(〜2025):用途別(食品、製薬、製造、化学、環境)、疾病別(呼吸器、標準、尿路感染症)、製品別(機器、分析装置、試薬)、エンドユーザー別(病院、診断ラボ、学界)

◆英語タイトル:Clinical Microbiology Market by Application (Food, Pharma, Manufacturing, Chemical, Environment), Disease (Respiratory, Std, Uti), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnostic Lab, Academia) - Global Forecast to 2025
◆商品コード:MD 3092
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年10月20日
◆ページ数:220
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Marketsandmarkets社は臨床微生物学の世界市場が2020年39億ドルから2025年53億ドルまで、年平均6.5%成長すると予測しています。本調査レポートでは、臨床微生物学の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、用途別(医薬品、食品検査、臨床、エネルギー、化学・材料製造)分析、製品別(機器、試薬)分析、疾患別(呼吸器疾患、菌血症、胃腸疾患、性感染症、尿路感染症)分析、エンドユーザー別(病院・診断センター、カスタムラボサービスプロバイダー、アカデミック&研究所)分析、地域別分析、競争状況、企業評価・情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・臨床微生物学の世界市場規模:用途別(医薬品、食品検査、臨床、エネルギー、化学・材料製造)
・臨床微生物学の世界市場規模:製品別(機器、試薬)
・臨床微生物学の世界市場規模:疾患別(呼吸器疾患、菌血症、胃腸疾患、性感染症、尿路感染症)
・臨床微生物学の世界市場規模:エンドユーザー別(病院・診断センター、カスタムラボサービスプロバイダー、アカデミック&研究所)
・臨床微生物学の世界市場規模:地域別
・競争状況
・企業評価・情報
【レポートの概要】

“The global clinical microbiology market size is projected to reach USD 5.3 billion by 2025 from USD 3.9 billion in 2020, at a CAGR of 6.5%.”Factors such as the technological advancements in the market are propelling the growth of the clinical microbiology market. Additionally, rising inclination epidemics like COVID-19 and investments from private and public sectors affect the growth of clinical microbiology market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of this market.

The recent COVID-19 global pandemic has also impacted the clinical microbiology market. Demand from the main end-users has declined as key regions, and countries have imposed social distancing rules and lockdowns. This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens.

“The reagent segment to witness the highest growth rate in the clinical microbiology market, by product, during the forecast period.”
The reagent segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the high prevalence of infectious diseases across major markets (resulting in a growing number of clinical diagnostic procedures), the increasing trend of reagent rental agreements along with instrument sales, and a rising number of life science researches in the field of specific reagents for targeted infectious disease diagnosis and treatment, especially across emerging countries.

“The respiratory diseases accounted for the largest share of the clinical microbiology market, by diseases, in 2019.”
The respiratory diseases segment accounted for the largest share of the clinical microbiology market in 2019. This segment is also estimated to register the highest CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to factors such as the large patient population suffering from respiratory diseases, rising prevalence of target respiratory diseases (such as TB, asthma, COPD, and bronchitis) across developing countries, and growth in the number of epidemic outbreaks of respiratory infections.

“The hospitals & diagnostics centers segment accounted for the largest share of the clinical microbiology, by end-users, in 2019”
The hospitals and diagnostic centers segment accounted for the largest market share in 2019. The large share of this segment is attributed to the high incidence of target diseases (such as tuberculosis, HIV-AIDS, malaria, and epidemic diseases), availability of technologically advanced products (such as molecular diagnostic products and PCR and NGS-based instruments) for infectious disease diagnosis, growing awareness among doctors and clinicians regarding the advantages offered by molecular diagnostic products for fast and effective disease diagnosis, and ongoing expansion of healthcare infrastructure across emerging countries.

“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The clinical microbiology market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Government efforts to increase awareness related to genome-based infectious disease diagnosis, supportive regulations for the development and commercialization of advanced clinical microbiology products, rising healthcare expenditure, an increasing number of hospitals and clinical diagnostic laboratories in India and China, expanding research base across India, China, and Japan, and the increasing incidence of infectious diseases are the major factors driving the growth of the APAC clinical microbiology market.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
• By Designation: C-level: 23%, D-level: 30%, and Others: 47%
• By Region: Europe: 30%, North America: 40%, APAC: 22%, Latin America: 6%, and the Middle East & Africa: 2%

The major players operating in the orthopedic braces and supports market are bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland). Other prominent players include Thermo Fisher Scientific (US), QIAGEN (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker Corporation (US), and Hologic (US).

Research Coverage
This report studies the clinical microbiology market based on the product, application, diseases, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the clinical microbiology market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 32
1.3 MARKET SCOPE 33
1.3.1 MARKETS COVERED 33
1.3.2 YEARS CONSIDERED FOR THE STUDY 33
1.4 CURRENCY 34
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 36
FIGURE 1 RESEARCH DESIGN 36
2.1 SECONDARY DATA 37
2.1.1 SECONDARY SOURCES 38
2.2 PRIMARY DATA 39
FIGURE 2 BREAKDOWN OF PRIMARIES: CLINICAL MICROBIOLOGY MARKET 39
2.3 MARKET ESTIMATION METHODOLOGY 39
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 40
2.3.1 REVENUE MAPPING-BASED MARKET ESTIMATION 40
2.3.2 PROCEDURE-BASED MARKET ESTIMATION 41
FIGURE 4 MARKET SIZE ESTIMATION: CLINICAL MICROBIOLOGY MARKET 41
2.3.3 PRIMARY RESEARCH VALIDATION 42
2.4 DATA TRIANGULATION 42
FIGURE 5 DATA TRIANGULATION METHODOLOGY 43
2.5 RESEARCH ASSUMPTIONS 43
2.6 RESEARCH LIMITATIONS 44
3 EXECUTIVE SUMMARY 45
FIGURE 6 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 45
FIGURE 7 CLINICAL MICROBIOLOGY MARKET, BY DISEASE,
2020 VS. 2025 (USD MILLION) 46
FIGURE 8 MICROBIOLOGY TESTING MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 47
FIGURE 9 CLINICAL MICROBIOLOGY MARKET SHARE, BY END USER, 2020 VS. 2025 48
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL MICROBIOLOGY MARKET 49

4 PREMIUM INSIGHTS 50
4.1 CLINICAL MICROBIOLOGY MARKET OVERVIEW 50
FIGURE 11 RISING INCIDENCE OF INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE CLINICAL MICROBIOLOGY MARKET 50
4.2 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 51
FIGURE 12 INSTRUMENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025 51
4.3 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER AND COUNTRY (2019) 52
FIGURE 13 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC CLINICAL MICROBIOLOGY MARKET IN 2019 52
4.4 GEOGRAPHIC ANALYSIS: CLINICAL MICROBIOLOGY MARKET, BY DISEASE (2019) 53
FIGURE 14 RESPIRATORY DISEASES SEGMENT DOMINATES THE GLOBAL CLINICAL MICROBIOLOGY MARKET 53
4.5 CLINICAL MICROBIOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
5.2.1 DRIVERS 56
5.2.1.1 Technological advancements in disease diagnostics 56
5.2.1.2 Rising incidence of infectious diseases and growing outbreaks of epidemics 57
5.2.1.3 Increased funding and public-private investments 57
5.2.2 RESTRAINTS 58
5.2.2.1 Limited reimbursement policies for microbiology testing procedures 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Improving healthcare infrastructure across emerging countries 59
5.2.4 CHALLENGES 59
5.2.4.1 Operational barriers related to the use of diagnostic tests 59
5.2.4.2 Bundled sales of microbiology testing products – A key challenge for small and emerging reagent manufacturers 60
5.3 IMPACT OF THE COVID-19 PANDEMIC ON THE CLINICAL MICROBIOLOGY MARKET 60
5.4 REGULATORY SCENARIO 61
5.5 ECOSYSTEM COVERAGE 63
5.6 TECHNOLOGY ANALYSIS 63
5.7 PRICING ANALYSIS 64
TABLE 1 CLINICAL MICROBIOLOGY PRICING ANALYSIS, BY PRODUCT, 2019 (USD) 64

6 MICROBIOLOGY TESTING MARKET, BY APPLICATION 65
6.1 INTRODUCTION 66
TABLE 2 MICROBIOLOGY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 66
6.2 PHARMACEUTICAL 66
6.2.1 GROWING VOLUME OF PHARMACEUTICAL DRUGS MANUFACTURED IS THE MAJOR FACTOR DRIVING MARKET GROWTH 66
TABLE 3 MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 67
6.3 FOOD TESTING 67
6.3.1 FOOD TESTING IS THE FASTEST-GROWING APPLICATION SEGMENT OF THE MARKET 67
TABLE 4 MICROBIOLOGY TESTING MARKET FOR FOOD TESTING APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 68
6.4 CLINICAL 68
6.4.1 GROWING PROCEDURAL VOLUME OF CLINICAL DIAGNOSTIC TESTS WILL PROPEL MARKET GROWTH 68
TABLE 5 MICROBIOLOGY TESTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 69
6.5 ENERGY 70
6.5.1 INCREASING CONSUMPTION & PRODUCTION OF BIOFUEL TO DRIVE MARKET GROWTH 70
TABLE 6 MICROBIOLOGY TESTING MARKET FOR ENERGY APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 70
6.6 CHEMICAL & MATERIAL MANUFACTURING 71
6.6.1 CHEMICAL & MATERIAL MANUFACTURING APPLICATIONS TO WITNESS STEADY GROWTH DURING THE FORECAST PERIOD 71
TABLE 7 MICROBIOLOGY TESTING MARKET FOR CHEMICAL AND MATERIAL MANUFACTURING APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 71
6.7 ENVIRONMENTAL 72
6.7.1 RISING INCIDENCE OF AIR- & WATER-BORNE DISEASES TO SUPPORT MARKET GROWTH 72
TABLE 8 MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 72
7 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT 73
7.1 INTRODUCTION 74
TABLE 9 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 74
7.2 INSTRUMENTS 74
TABLE 10 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 74
TABLE 11 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY DISEASE,
2018–2025 (USD MILLION) 75
TABLE 12 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY END USER,
2018–2025 (USD MILLION) 75
TABLE 13 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 76
7.2.1 LABORATORY INSTRUMENTS 76
TABLE 14 LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 77
TABLE 15 LABORATORY INSTRUMENTS MARKET, BY DISEASE,
2018–2025 (USD MILLION) 77
TABLE 16 LABORATORY INSTRUMENTS MARKET, BY END USER,
2018–2025 (USD MILLION) 78
TABLE 17 LABORATORY INSTRUMENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 78
7.2.1.1 Incubators 78
7.2.1.1.1 Incubators will continue to dominate the clinical microbiology instruments market 78
TABLE 18 INCUBATORS MARKET, BY REGION, 2018–2025 (USD MILLION) 79
7.2.1.2 Gram stainers 79
7.2.1.2.1 Gram stainers are among the most widely used clinical microbiology instruments 79
TABLE 19 GRAM STAINERS MARKET, BY REGION, 2018–2025 (USD MILLION) 79
7.2.1.3 Bacterial colony counters 80
7.2.1.3.1 Bacterial colony counters are used during diagnostic procedures 80
TABLE 20 BACTERIAL COLONY COUNTERS MARKET, BY REGION,
2018–2025 (USD MILLION) 80
7.2.1.4 Autoclave sterilizers 80
7.2.1.4.1 Autoclave sterilizers are used to eliminate the risk of microbial contamination 80
TABLE 21 AUTOCLAVE STERILIZERS MARKET, BY REGION, 2018–2025 (USD MILLION) 81
7.2.1.5 Microbial air samplers 81
7.2.1.5.1 Microbial air samplers are significant instruments used in diagnosing airborne diseases 81
TABLE 22 MICROBIAL AIR SAMPLERS MARKET, BY REGION,
2018–2025 (USD MILLION) 81
7.2.1.6 Blood culture systems 82
7.2.1.6.1 Blood culture systems are used for end-to-end blood sample processing 82
TABLE 23 BLOOD CULTURE SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 82
7.2.1.7 Anaerobic culture systems 82
7.2.1.7.1 Anaerobic culture systems help to maintain an anaerobic environment 82
TABLE 24 ANAEROBIC CULTURE SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 83
7.2.1.8 Microbial culture systems 83
7.2.1.8.1 Microbial culture systems are automated systems for the culturing of samples 83
TABLE 25 MICROBIAL CULTURE SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 83
7.2.1.9 Petri dish fillers 84
7.2.1.9.1 Petri dish fillers are designed to work reliably in the absence of the operator 84
TABLE 26 PETRI DISH FILLERS MARKET, BY REGION, 2018–2025 (USD MILLION) 84
7.2.1.10 Other laboratory instruments 84
TABLE 27 OTHER LABORATORY INSTRUMENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 85
7.2.2 MICROBIOLOGY ANALYZERS 85
TABLE 28 MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 86
TABLE 29 MICROBIOLOGY ANALYZERS MARKET, BY DISEASE,
2018–2025 (USD MILLION) 86
TABLE 30 MICROBIOLOGY ANALYZERS MARKET, BY END USER,
2018–2025 (USD MILLION) 86
TABLE 31 MICROBIOLOGY ANALYZERS MARKET, BY REGION,
2018–2025 (USD MILLION) 87
7.2.2.1 Molecular diagnostic instruments 87
7.2.2.1.1 Molecular diagnostic instruments to register the highest growth in the forecast period 87
TABLE 32 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 87
7.2.2.2 Microscopes 88
7.2.2.2.1 Microscopes are particularly helpful during the preliminary identification of pathogens 88
TABLE 33 MICROSCOPES MARKET, BY REGION, 2018–2025 (USD MILLION) 88
7.2.2.3 Mass spectrometers 88
7.2.2.3.1 High accuracy of mass spectrometers to drive their adoption 88
TABLE 34 MASS SPECTROMETERS MARKET, BY REGION, 2018–2025 (USD MILLION) 89
7.3 REAGENTS 89
TABLE 35 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 89
TABLE 36 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY DISEASE,
2018–2025 (USD MILLION) 90
TABLE 37 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY END USER,
2018–2025 (USD MILLION) 90
TABLE 38 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY REGION,
2018–2025 (USD MILLION) 90
7.3.1 PATHOGEN-SPECIFIC KITS 91
7.3.1.1 Pathogen-specific kits provide efficient mechanical disruption of difficult-to-lyse microbes 91
TABLE 39 PATHOGEN-SPECIFIC KITS MARKET, BY REGION, 2018–2025 (USD MILLION) 91
7.3.2 GENERAL REAGENTS 91
7.3.2.1 General reagents offer significant data reproducibility 91
TABLE 40 GENERAL REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 92

8 CLINICAL MICROBIOLOGY MARKET, BY DISEASE 93
8.1 INTRODUCTION 94
TABLE 41 CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018–2025 (USD MILLION) 94
8.2 RESPIRATORY DISEASES 94
8.2.1 RESPIRATORY DISEASES SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 94
TABLE 42 CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES,
BY REGION, 2018–2025 (USD MILLION) 95
8.3 BLOODSTREAM INFECTIONS 96
8.3.1 BLOODSTREAM INFECTIONS CAN LEAD TO A REDUCED RISK OF ANTIBIOTIC RESISTANCE 96
TABLE 43 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS,
BY REGION, 2018–2025 (USD MILLION) 96
8.4 GASTROINTESTINAL DISEASES 97
8.4.1 GASTROINTESTINAL DISEASES HAVE A HIGHER PREVALENCE IN DEVELOPING COUNTRIES 97
TABLE 44 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES,
BY REGION, 2018–2025 (USD MILLION) 97
8.5 SEXUALLY TRANSMITTED DISEASES 98
8.5.1 RISING PREVALENCE OF STDS ACROSS MAJOR MARKETS TO PROPEL THE ADOPTION OF CLINICAL MICROBIOLOGY PRODUCTS 98
TABLE 45 CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018–2025 (USD MILLION) 98
8.6 URINARY TRACT INFECTIONS 99
8.6.1 GROWING NUMBER OF UTI CASES WILL DRIVE MARKET GROWTH 99
TABLE 46 CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS,
BY REGION, 2018–2025 (USD MILLION) 99
8.7 PERIODONTAL DISEASES 100
8.7.1 EXPANDING PRODUCT PIPELINES OF MARKET PLAYERS TO SUPPORT MARKET GROWTH 100
TABLE 47 CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES,
BY REGION, 2018–2025 (USD MILLION) 100
8.8 OTHER DISEASES 101
TABLE 48 CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2018–2025 (USD MILLION) 101
9 CLINICAL MICROBIOLOGY MARKET, BY END USER 102
9.1 INTRODUCTION 103
TABLE 49 CLINICAL MICROBIOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 103
9.2 HOSPITALS & DIAGNOSTIC CENTERS 103
9.2.1 HOSPITALS & DIAGNOSTIC CENTERS ARE THE LARGEST END USERS OF CLINICAL MICROBIOLOGY PRODUCTS 103
TABLE 50 CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018–2025 (USD MILLION) 104

9.3 CUSTOM LAB SERVICE PROVIDERS 104
9.3.1 CUSTOM LAB SERVICE PROVIDERS ARE THE FASTEST-GROWING END USERS OF THE CLINICAL MICROBIOLOGY MARKET 104
TABLE 51 CLINICAL MICROBIOLOGY MARKET FOR CUSTOM LAB SERVICE PROVIDERS, BY REGION, 2018–2025 (USD MILLION) 104
9.4 ACADEMIC & RESEARCH INSTITUTES 105
9.4.1 HIGH PREVALENCE OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH 105
TABLE 52 CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 105
10 CLINICAL MICROBIOLOGY MARKET, BY REGION 106
10.1 INTRODUCTION 107
TABLE 53 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 107
10.2 NORTH AMERICA 107
FIGURE 17 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 108
TABLE 54 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 108
TABLE 55 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 109
TABLE 56 NORTH AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 57 NORTH AMERICA: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 109
TABLE 58 NORTH AMERICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 110
TABLE 59 NORTH AMERICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 110
TABLE 60 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE,
2018–2025 (USD MILLION) 110
TABLE 61 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 111
10.2.1 US 111
10.2.1.1 The US is the largest market for clinical microbiology products 111
TABLE 62 US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 111
TABLE 63 US: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 64 US: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 65 US: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 66 US: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 113
10.2.2 CANADA 113
10.2.2.1 Growing number of clinical diagnostic tests to drive market growth in Canada 113
TABLE 67 CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 114
TABLE 68 CANADA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 114
TABLE 69 CANADA: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 114
TABLE 70 CANADA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 115
TABLE 71 CANADA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 115
10.3 EUROPE 115
TABLE 72 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 116
TABLE 73 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 116
TABLE 74 EUROPE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
TABLE 75 EUROPE: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 117
TABLE 76 EUROPE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 117
TABLE 77 EUROPE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 118
TABLE 78 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE,
2018–2025 (USD MILLION) 118
TABLE 79 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 118
10.3.1 GERMANY 119
10.3.1.1 Germany is the largest and fastest-growing market for clinical microbiology products in Europe 119
TABLE 80 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 119
TABLE 81 GERMANY: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 119
TABLE 82 GERMANY: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
TABLE 83 GERMANY: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
TABLE 84 GERMANY: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
10.3.2 UK 121
10.3.2.1 High per capita healthcare expenditure in the country to support market growth 121
TABLE 85 UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 121
TABLE 86 UK: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 87 UK: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 88 UK: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 89 UK: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
10.3.3 FRANCE 123
10.3.3.1 Increasing incidence of infectious diseases to drive market growth 123
TABLE 90 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 123
TABLE 91 FRANCE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 92 FRANCE: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 93 FRANCE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 94 FRANCE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
10.3.4 ITALY 125
10.3.4.1 Increasing R&D investments by pharmaceutical companies will propel the demand for clinical microbiology products 125
TABLE 95 ITALY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 125
TABLE 96 ITALY: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 126
TABLE 97 ITALY: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 98 ITALY: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 99 ITALY: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 127
10.3.5 SPAIN 127
10.3.5.1 Growth of Spain’s food and dairy industry will support market growth 127
TABLE 100 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 127
TABLE 101 SPAIN: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 128
TABLE 102 SPAIN: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 103 SPAIN: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 104 SPAIN: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 129
10.3.6 REST OF EUROPE 129
TABLE 105 ROE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 129
TABLE 106 ROE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 129
TABLE 107 ROE: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 108 ROE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 109 ROE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
10.4 ASIA PACIFIC 131
FIGURE 18 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 132
TABLE 110 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 133
TABLE 111 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 133
TABLE 112 ASIA PACIFIC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 133
TABLE 113 ASIA PACIFIC: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 114 ASIA PACIFIC: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 115 ASIA PACIFIC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 135
TABLE 116 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE,
2018–2025 (USD MILLION) 135
TABLE 117 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 135
10.4.1 JAPAN 136
10.4.1.1 Japan is the largest market for clinical microbiology in the APAC 136
TABLE 118 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 136
TABLE 119 JAPAN: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 136
TABLE 120 JAPAN: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 137
TABLE 121 JAPAN: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 137
TABLE 122 JAPAN: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 137
10.4.2 CHINA 138
10.4.2.1 China to register the highest growth during the forecast period 138
TABLE 123 CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 138
TABLE 124 CHINA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 139
TABLE 125 CHINA: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
TABLE 126 CHINA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
TABLE 127 CHINA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 140
10.4.3 INDIA 140
10.4.3.1 High incidence of infectious diseases in the country to drive the demand for clinical microbiology products 140
TABLE 128 INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 141
TABLE 129 INDIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 141
TABLE 130 INDIA: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 141
TABLE 131 INDIA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 142
TABLE 132 INDIA: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 142
10.4.4 SOUTH KOREA 142
10.4.4.1 Growing presence of key market players in the region to support market growth 142
TABLE 133 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 143
TABLE 134 SOUTH KOREA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 143
TABLE 135 SOUTH KOREA: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 143
TABLE 136 SOUTH KOREA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 144
TABLE 137 SOUTH KOREA: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 144
10.4.5 AUSTRALIA 144
10.4.5.1 Limitations with respect to research activities are expected to hamper the growth of the clinical microbiology market in Australia 144
TABLE 138 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 145
TABLE 139 AUSTRALIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 145
TABLE 140 AUSTRALIA: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 145
TABLE 141 AUSTRALIA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 146
TABLE 142 AUSTRALIA: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 146
10.4.6 REST OF APAC 146
TABLE 143 ROAPAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 146
TABLE 144 ROAPAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 147
TABLE 145 ROAPAC: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 147
TABLE 146 ROAPAC: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 147
TABLE 147 ROAPAC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 148

10.5 LATIN AMERICA 148
TABLE 148 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 149
TABLE 149 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 149
TABLE 150 LATIN AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 149
TABLE 151 LATIN AMERICA: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 150
TABLE 152 LATIN AMERICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 150
TABLE 153 LATIN AMERICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 151
TABLE 154 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE,
2018–2025 (USD MILLION) 151
TABLE 155 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 151
10.5.1 BRAZIL 152
10.5.1.1 Brazil is the largest market in Latin America for clinical microbiology products 152
TABLE 156 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 152
TABLE 157 BRAZIL: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 152
TABLE 158 BRAZIL: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 153
TABLE 159 BRAZIL: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 153
TABLE 160 BRAZIL: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 153
10.5.2 MEXICO 154
10.5.2.1 Reluctance of healthcare professionals to adopt advanced diagnostic technologies to hamper the market growth 154
TABLE 161 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 154
TABLE 162 MEXICO: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 155
TABLE 163 MEXICO: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 155
TABLE 164 MEXICO: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 155
TABLE 165 MEXICO: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 156
10.5.3 REST OF LATIN AMERICA 156
TABLE 166 ROLATAM: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 156
TABLE 167 ROLATAM: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 157
TABLE 168 ROLATAM: LABORATORY INSTRUMENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 157
TABLE 169 ROLATAM: MICROBIOLOGY ANALYZERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 157
TABLE 170 ROLATAM: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 158
10.6 MIDDLE EAST & AFRICA 158
10.6.1 INCREASING GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE WILL SUPPORT MARKET GROWTH 158
TABLE 171 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 158
TABLE 172 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 159
TABLE 173 MIDDLE EAST & AFRICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 159
TABLE 174 MIDDLE EAST & AFRICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 160
TABLE 175 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY REAGENTS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 160
TABLE 176 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018–2025 (USD MILLION) 160
TABLE 177 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION) 161
11 COMPETITIVE LANDSCAPE 162
11.1 OVERVIEW 162
FIGURE 19 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE CLINICAL MICROBIOLOGY MARKET, JANUARY 2017–AUGUST 2020 162
11.2 MARKET SHARE ANALYSIS 163
FIGURE 20 CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2019 163
11.3 COMPETITIVE SCENARIO 164
FIGURE 21 PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED
BY MARKET PLAYERS 164
11.3.1 KEY PRODUCT LAUNCHES & APPROVALS 164
11.3.2 KEY PARTNERSHIPS & COLLABORATIONS 165
11.3.3 KEY ACQUISITIONS 165
11.3.4 KEY EXPANSIONS 165
12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 166
12.1 COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY 166
12.1.1 VENDOR INCLUSION CRITERIA 166
12.1.2 STARS 166
12.1.3 EMERGING LEADERS 166
12.1.4 PERVASIVE 166
12.1.5 PARTICIPANTS 166
FIGURE 22 CLINICAL MICROBIOLOGY MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 167
12.2 COMPANY PROFILES 168
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12.2.1 3M 168
FIGURE 23 3M: COMPANY SNAPSHOT (2019) 168
12.2.2 ABBOTT LABORATORIES 169
FIGURE 24 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 170
12.2.3 AGILENT TECHNOLOGIES 177
FIGURE 25 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019) 177
12.2.4 BECTON, DICKINSON AND COMPANY 179
FIGURE 26 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 179
12.2.5 BIOMÉRIEUX 183
FIGURE 27 BIOMÉRIEUX: COMPANY SNAPSHOT (2019) 183
12.2.6 BIO-RAD LABORATORIES 188
FIGURE 28 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019) 188
12.2.7 BRUKER CORPORATION 191
FIGURE 29 BRUKER CORPORATION: COMPANY SNAPSHOT (2019) 191
12.2.8 DANAHER CORPORATION 193
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 193
12.2.9 HOLOGIC, INC. 198
FIGURE 31 HOLOGIC: COMPANY SNAPSHOT (2019) 198
12.2.10 MERCK KGAA 202
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019) 202
12.2.11 NEOGEN CORPORATION 204
FIGURE 33 NEOGEN CORPORATION: COMPANY SNAPSHOT (2019) 204
12.2.12 QIAGEN 206
FIGURE 34 QIAGEN: COMPANY SNAPSHOT (2019) 206
12.2.13 ROCHE DIAGNOSTICS 208
FIGURE 35 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019) 208
12.2.14 SHIMADZU CORPORATION 210
FIGURE 36 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2019) 210
12.2.15 THERMO FISHER SCIENTIFIC 212
FIGURE 37 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019) 212
12.2.16 EMERGING PLAYERS 216
12.2.16.1 Biotechnology Solutions 216
12.2.16.2 Hardy Diagnostics 216
12.2.16.3 Liofilchem 217
12.2.16.4 Rapid Micro Biosystems 217
12.2.16.5 TCS Biosciences 218
(Business Overview, Products Offered, Recent Developments, MnM View)*
13 APPENDIX 219
13.1 DISCUSSION GUIDE 219
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 225
13.3 AVAILABLE CUSTOMIZATIONS 227
13.4 RELATED REPORTS 227
13.5 AUTHOR DETAILS 228



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[臨床微生物学の世界市場予測(〜2025):用途別(食品、製薬、製造、化学、環境)、疾病別(呼吸器、標準、尿路感染症)、製品別(機器、分析装置、試薬)、エンドユーザー別(病院、診断ラボ、学界)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆